September 17, 2025

‘Death by a Thousand Cuts’

Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care.

KFF Health News

September 16, 2025

State’s Largest HIV Outbreak Raises Alarms

Public health experts cite syringe shortages and encampment clearings as drivers of Penobscot County’s historic HIV outbreak.

KFF Health News

September 16, 2025

Lateral Positioning Reduced Hypoxaemia After Anesthesia

Lateral positioning shortens PACU stay and lowers airway intervention rates in sedated adults.

Conexiant

September 15, 2025

FDA Approves First Intranasal Loop Diuretic

The FDA has approved Enbumyst offering a self-administered outpatient option for managing edema in patients with heart failure, liver disease, and kidney disease.

Conexiant

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 05, 2025

Dr. Jordan Strom Lays the Scene for ASE 2025

As ASE marks its 50th anniversary in Nashville, the meeting will showcase the latest echocardiography research, updated guidelines, the Kalmanson Lecture, and discussions on workforce challenges.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 02, 2025

Sotatercept Maintains One-Year Gains in PAH

Ongoing follow-up evaluates long-term sotatercept use in pulmonary arterial hypertension, focusing on sustained efficacy, adverse event profiles, and clinical risk classification.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant